https://www.indianpharmapost.com/phase-3-data-show-dupixent-improves-signs-and-symptoms-of-prurigo-nodularis-117562022-03-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/aster-dm-healthcare-signs-mou-with-tamil-nadu-govt-to-invest-rs-500-crore-117572022-03-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/nmpa-approves-hansizhuang-its-first-monoclonal-antibody-117582022-03-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/sciencemedia-and-apex-mobile-clinical-research-sign-partnership-for-clinical-trial-training-117592022-03-27T00:00:00+05:30always0.9